All In Biotech

Drug Trial Radar · NCT04809376

Treatment Effects of Subcutaneous Injections of Pentosan Polysulfate Sodium vs Placebo in Participants With Knee OA Pain

A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain

Last checked: Nov 19, 2026Latest source record: Apr 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 602 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

602

Actual

Start

Oct 19, 2021

Primary completion

Oct 15, 2024

Study completion Jan 6, 2025

Sponsor

Sponsor type
Industry
First posted
Mar 22, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with subcutaneous injections of placebo in participants with knee osteoarthritis pain. Study details include: * The study duration will be up to 31 weeks per participant * The treatment duration will be 6 weeks. * The visit frequency will be twice weekly during treatment. * The visit frequency will be every 4 weeks during the follow-up period.

Conditions

  • Osteoarthritis, Knee

Interventions

  • Pentosan Polysulfate Sodium twice weeklyDrug

    Subcutaneous Injection, 1.5mg/kg Ideal body Weight (IBW)

  • Placebo (Sodium Chloride Injection, 0.9%)Drug

    Placebo to match PPS

  • Pentosan Polysulfate Sodium Fixed DoseDrug

    Subcutaneous Injection, 100/150/180 mg if \<65kg/ ≥ 65 kg and ≤ 90kg/ \>90 kg IBW

  • Pentosan Polysulfate Sodium once weeklyDrug

    Subcutaneous Injection, 2.0mg/kg Ideal body Weight (IBW)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline at Day 56 in knee pain as assessed by the average pain sub-scale score of the WOMAC® NRS 3.1 Index.Time frame: Baseline, Day 56

Locations

33 sites in 2 countries. Site status is shown where the registry gives one.

  • Alliance for Multispecialty Research - Tempe

    Tempe, Arizona

  • Fiel Family and Sports Medicine

    Tempe, Arizona

  • Tucson Orthopaedic Institute

    Tucson, Arizona

  • Core Healthcare Group

    Cerritos, California

  • Biosolutions Clinical Research Center

    La Mesa, California

  • Providence Clinical Research

    North Hollywood, California

  • Prospective Research Innovations Inc.

    Rancho Cucamonga, California

  • Encompass Clinical Research

    Spring Valley, California

  • Clinical Research of West Florida- Clearwater

    Clearwater, Florida

  • University Clinical Research-Deland

    DeLand, Florida

  • LMG Research

    Miami, Florida

  • Well Pharma Medical Research, Corp.

    Miami, Florida

  • Progressive Medical Research

    Port Orange, Florida

  • Clinical Research of West Florida

    Tampa, Florida

  • Conquest Research

    Winter Park, Florida

  • Northwestern University Feinberg School of Medicine

    Chicago, Illinois

  • Alliance for Multispecialty Research - Newton

    Newton, Kansas

  • Alliance for Multispecialty Research - Wichita West

    Wichita, Kansas

  • Alliance for Multispecialty Research - Wichita East

    Wichita, Kansas

  • Tandem Clinical Research

    Marrero, Louisiana

  • Alliance for Multispecialty Research - Las Vegas

    Las Vegas, Nevada

  • Kaplan Medical Research

    Las Vegas, Nevada

  • Coastal Carolina Research Center

    North Charleston, South Carolina

  • Alliance for Multispecialty Research - Knoxville

    Knoxville, Tennessee

  • FutureSearch Trials - Austin

    Austin, Texas

  • Clinical Investigations of Texas

    Plano, Texas

  • Clinical Trials of Texas, Inc.

    San Antonio, Texas

  • Diagnostics Research Group - Northwest San Antonio

    San Antonio, Texas

  • Discovery Clinical Trials

    San Antonio, Texas

  • Australian Clinical Research Network

    Maroubra, New South Wales, Australia

  • Griffith University

    Southport, Queensland, Australia

  • Sportsmed

    Stepney, South Australia, Australia

  • Linear Clinical Research Limited

    Nedlands, Western Australia, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.